Cardiovascular risk factors
| Location | Patients with COPD | Smokers | Non-smokers | p Value | |||
|---|---|---|---|---|---|---|---|
| Overall | Patients with COPD vs smokers | Patients with COPD vs non-smokers | Smokers vs non-smokers | ||||
| Diabetes | 66 (10%) | 14 (7%) | 3 (4%) | 0.158 | 0.213 | 0.115 | 0.402 |
| Hypertension | 260 (41%) | 31 (17%) | 17 (25%) | <0.001 | <0.001 | 0.015 | 0.115 |
| Statin therapy | 173 (26%) | 27 (14%) | 8 (11%) | <0.001 | <0.001 | 0.007 | 0.621 |
| Patient-reported cardiovascular disease* | 357 (53%) | 45 (23%) | 24 (34%) | <0.001 | <0.001 | 0.002 | 0.064 |
Number (%).
Cohorts were compared via Cochran–Mantel–Haenszel tests.
*‘Heart trouble’, angina or ‘heart attack’.